SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-024959
Filing Date
2022-06-30
Accepted
2022-06-30 16:50:44
Documents
14
Period of Report
2022-06-27
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hsto-8k_20220627.htm   iXBRL 8-K 46443
2 EX-3.1 hsto-ex31_37.htm EX-3.1 15740
3 EX-3.2 hsto-ex32_38.htm EX-3.2 12788
  Complete submission text file 0001564590-22-024959.txt   213679

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hsto-20220627.xsd EX-101.SCH 5601
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20220627_lab.xml EX-101.LAB 20069
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20220627_pre.xml EX-101.PRE 11943
8 EXTRACTED XBRL INSTANCE DOCUMENT hsto-8k_20220627_htm.xml XML 3678
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 221058569
SIC: 2834 Pharmaceutical Preparations